GL1X · GenesisL1 explorer

MolNFT v1 · #102548 · protein

Crystal structure of stabilized tem-1 beta-lactamase variant V.13 carrying R164S mutation

4OP5 · Extended spectrum beta-lactamase tem-63: “Crystal structure of stabilized tem-1 beta-lactamase variant V.13 carrying R164S mutation”. X-ray diffraction, 1 ligand (CA), 1 pocket (best druggability 0.34). MolNFT v1 #102548 on…

PDB
4OP5
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Extended spectrum beta-lactamase tem-63
UniProt
Q9AGJ5
Ligands
CA
Pockets
1 · best druggability 0.34

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AExtended spectrum beta-lactamase tem-63protein26344% helix, 18% strandQ9AGJ5

Ligands and binding sites

  • CA · Calcium ion · metal · chains A
  • PG4 · Tetraethylene glycol · additive · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.340.7618MES

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4OP5 · Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.